Literature DB >> 33983562

Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress.

Qichuang Liu1, Maoyuan Mu1, Huan Chen1, Guoyuan Zhang1, Yanqing Yang1, Jun Chu1, Ying Li1, Fangwan Yang1, Shide Lin2.   

Abstract

The effects of hepatocyte steatosis on hepatitis B virus (HBV) DNA replication and HBV-related antigen secretion are incompletely understood. The aims of this study are to explore the effects and mechanism of hepatocyte steatosis on HBV replication and secretion. Stearic acid (SA) and oleic acid (OA) were used to induce HepG2.2.15 cell steatosis in this study. The expressions of glucose-regulated protein 78 (GRP78), phosphorylation of protein kinase R-like endoplasmic reticulum (ER) kinase (p-PERK), and eukaryotic translation initiation factor 2α (p-eIF2α) were detected by Western blotting (WB). HBV DNA, HBsAg, and HBeAg in the supernatant were determined by real-time fluorescent polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay. Intracellular HBV DNA, HBsAg level, and HBV RNA were measured by real-time fluorescent PCR, WB, and real-time quantitative reverse transcriptase-PCR, respectively. The results showed that SA and OA significantly increased intracellular lipid droplets and triglyceride levels. SA and OA significantly induced GRP78, p-PERK, and p-eIF2α expressions from 24 to 72 h. 4-phenylbutyric acid (PBA) alleviated ER stress induced by SA. SA promoted intracellular HBsAg and HBV DNA accumulation; however, it inhibited the transcript of HBV 3.5 kb mRNA and S mRNA. The secretion of HBsAg and HBV DNA inhibited by SA or OA could be partially restored by pretreatment with PBA but not by inhibiting GRP78 expression with siRNA. Hepatocyte steatosis inhibits HBsAg and HBV DNA secretion via induction of ER stress in hepatocytes, but not via induction of GRP78.

Entities:  

Keywords:  Endoplasmic reticulum stress; HBVDNA; HBsAg; HepG2.2.15 cell; Oleic acid; Stearic acid

Year:  2021        PMID: 33983562     DOI: 10.1007/s11010-021-04143-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.

Authors:  Lu Wang; Yijin Wang; Shuhong Liu; Xiangwei Zhai; Guangde Zhou; Fengmin Lu; Jingmin Zhao
Journal:  J Gastroenterol       Date:  2019-05-27       Impact factor: 7.527

2.  Involvement of endoplasmic reticulum in hepatitis B virus replication.

Authors:  Weiliang Xia; Yan Shen; Haiyang Xie; Shusen Zheng
Journal:  Virus Res       Date:  2006-07-25       Impact factor: 3.303

Review 3.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

Review 4.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

5.  Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model.

Authors:  Danqing Hu; Hongwu Wang; Hai Wang; Yaqi Wang; Xiaoyang Wan; Weiming Yan; Xiaoping Luo; Qin Ning
Journal:  Hepatol Int       Date:  2018-07-05       Impact factor: 6.047

6.  Hepatitis B virus infection and fatty liver in the general population.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Winnie Chiu-Wing Chu; Angel Mei-Ling Chim; Arlinking Ong; David Ka-Wai Yeung; Karen Kar-Lum Yiu; Shirley Ho-Ting Chu; Hoi-Yun Chan; Jean Woo; Francis Ka-Leung Chan; Henry Lik-Yuen Chan
Journal:  J Hepatol       Date:  2011-10-23       Impact factor: 25.083

7.  Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein.

Authors:  Cristina Dorobantu; Alina Macovei; Catalin Lazar; Raymond A Dwek; Nicole Zitzmann; Norica Branza-Nichita
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

Review 8.  Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?

Authors:  Jianbin Zhang; Shuangzhe Lin; Daixi Jiang; Mengting Li; Yuanwen Chen; Jun Li; Jiangao Fan
Journal:  Liver Int       Date:  2020-01-13       Impact factor: 5.828

9.  Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.

Authors:  Carsten Lambert; Reinhild Prange
Journal:  Virol J       Date:  2007-05-30       Impact factor: 4.099

10.  Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm.

Authors:  P D Garcia; J H Ou; W J Rutter; P Walter
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.